Milestone Pharmaceuticals, Inc. (MIST)
1.04
-0.02
(-1.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Milestone Pharmaceuticals Price : 1.04 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 1.06 | 1.06 | 1.02 | 1.04 | 1.562M |
| Aug 21, 2026 | 1.07 | 1.07 | 1.03 | 1.055 | 1.917M |
| Aug 20, 2026 | 1.09 | 1.129 | 1.02 | 1.03 | 2.178M |
| Aug 19, 2026 | 1.09 | 1.125 | 1.07 | 1.08 | 2.330M |
| Aug 18, 2026 | 1.07 | 1.11 | 1.050 | 1.07 | 1.481M |
| Aug 17, 2026 | 1.12 | 1.14 | 1.07 | 1.10 | 1.591M |
| Aug 14, 2026 | 1.07 | 1.10 | 1.04 | 1.10 | 2.167M |
| Aug 13, 2026 | 1.09 | 1.12 | 1.06 | 1.07 | 2.669M |
| Aug 12, 2026 | 1.08 | 1.19 | 1.04 | 1.125 | 5.786M |
| Aug 11, 2026 | 1.27 | 1.29 | 1.25 | 1.27 | 1.384M |
| Aug 10, 2026 | 1.23 | 1.29 | 1.20 | 1.26 | 1.627M |
| Aug 07, 2026 | 1.18 | 1.22 | 1.16 | 1.22 | 990172.0 |
| Aug 06, 2026 | 1.15 | 1.18 | 1.14 | 1.18 | 594658.0 |
| Aug 05, 2026 | 1.20 | 1.20 | 1.13 | 1.145 | 600826.0 |
| Aug 04, 2026 | 1.13 | 1.20 | 1.11 | 1.17 | 1.323M |
| Aug 03, 2026 | 1.12 | 1.12 | 1.08 | 1.12 | 935450.0 |
| Jul 31, 2026 | 1.17 | 1.174 | 1.080 | 1.11 | 1.063M |
| Jul 30, 2026 | 1.04 | 1.16 | 1.04 | 1.15 | 1.742M |
| Jul 29, 2026 | 1.12 | 1.12 | 1.01 | 1.04 | 2.231M |
| Jul 28, 2026 | 1.13 | 1.13 | 1.03 | 1.07 | 2.593M |
| Jul 27, 2026 | 1.17 | 1.199 | 1.12 | 1.13 | 1.214M |
| Jul 24, 2026 | 1.19 | 1.19 | 1.15 | 1.16 | 873936.0 |
| Jul 23, 2026 | 1.19 | 1.21 | 1.16 | 1.20 | 1.019M |
| Jul 22, 2026 | 1.22 | 1.228 | 1.185 | 1.19 | 673146.0 |
| Jul 21, 2026 | 1.18 | 1.23 | 1.165 | 1.23 | 456521.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.43 |
| NervGen Pharma Corp. | 2.00 |
| Clearmind Medicine, Inc. | 1.68 |
| Lexaria Bioscience Corp. | 10.54 |
| Target Group, Inc. (Canada) | 0.0010 |
Price Related Metrics
| PS Ratio | 52.34 |
| Price to Book Value | 7.107 |
| Earnings Yield | -66.71% |
| Market Cap | 129.48M |